Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 13Recruiting 3Unknown 2Terminated 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 30Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 9Neoplasm Metastasis 3Neoplasms 2Hodgkin Disease 2Adenocarcinoma of Lung 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Mesothelioma 1Malignant Solid Tumour 1Lymphoma, T-Cell, Peripheral 1Lymphoma 1Lung Diseases 1Breast Neoplasms, Male 1Advanced Non-Small Cell Lung Cancer 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Cyclophosphamide 24Mycophenolic Acid 15fludarabine phosphate 14fludarabine 13Whole-Body Irradiation 13Tacrolimus 12Rituximab 12Melphalan 12Filgrastim 11Cyclosporine 11Busulfan 11Radiotherapy 10Peripheral Blood Stem Cell Transplantation 10Antilymphocyte Serum 10Methotrexate 9Doxorubicin 9Gemcitabine 8Etoposide 8Brentuximab Vedotin 8Sirolimus 7pembrolizumab 6Vinblastine 6Nivolumab 6Methylprednisolone 6Granulocyte Colony-Stimulating Factor 6Alemtuzumab 6Dacarbazine 5Cytarabine 5Cord Blood Stem Cell Transplantation 5Carmustine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Hodgkin Disease × Vinorelbine × Clear all
NCT00920153 2016-09-16

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

French Innovative Leukemia Organisation

Phase 3 Terminated
442 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00225173 2014-08-27

Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease

Stanford University

Phase 2 Terminated
45 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡